Menu

First Wave BioPharma, Inc. FWBI

Full chart Compare
Set alert

Price alert · FWBI

All alert types
2.96 +2.96

Day range unavailable

52-week range unavailable

Revenue & Expenses

Net Loss → Expenses: $6.55MExpenses → Selling, General & Admin: $5.50MExpenses → Research & Development: $925.48KExpenses → Other Expenses: $127.57KNet Loss$6.55MExpenses$6.55MSelling, General & Admin$5.50MResearch & Development$925.48KOther Expenses$127.57KRevenue$36.25K

Latest period ending Dec 31, 2023 · select a line to chart its full history

FWBI annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-15.77M-12.68M-59.06M-26.43M-14.74M
-15.79M-14.63M-58.54M-32.67M-15.18M
-47.88-416.94-39,770.60-61,656.68-28,560.31
FWBI annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
3.74M1.40M8.29M6.09M216.84K
6.88M5.44M11.79M12.92M8.90M
3.28M2.70M19.61M15.56M4.29M
826.84K883.71K1.03M552.40K1.52M
3.60M2.74M-7.82M-2.64M4.62M
FWBI annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-12.38M-22.34M-32.29M-11.22M-14.03M
-500.00K0-10.32M87.35K-24.10K
15.23M15.74M44.76M17.05M13.14M
2.35M-6.60M2.16M5.91M-912.62K